Abstract
Hypoglycemia after Roux-en-Y gastric bypass is a rare and challenging condition. It occurs several months to years after surgery and has been more commonly seen in females. Severe hypoglycemia presents with symptoms of the Whipple’s triad that include signs as perspiration, palpitations, hunger, fatigue, confusion, aggression, tremor, syncope, a low plasma glucose concentration, and resolution of those symptoms after carbohydrate intake. Specific symptoms of hypoglycemia are categorized as autonomic or neuroglycopenic. Autonomic symptoms include anxiety, sweating, tremors, and palpitation. Neuroglycopenic symptoms comprehend confusion, weakness, light-headedness, dizziness, blurred vision, disorientation, and eventually, loss of consciousness, coma, and death.
When the patient is symptomatic, a fasting plasma glucose <50 mg/dl with serum insulin level is the first step for the decision-making process. Hyperinsulinemia is a condition in which the insulin level is above 6 mμU/ml and C-peptide elevated >5 ng/ml. A proinsulin level <5 pmol/L is a highly sensitive clue on eliminating insulinoma as a cause of endogenous hyperinsulinemia. The mixed meal tolerance test (MMTT) is the preferred provocative test. Most patients with post-RYGB hypoglycemia benefit from dietary restrictions or more complex nutritional and medical management strategies, including acarbose, nifedipine, diazoxide, GLP-1 receptor antagonist, and octreotide.
If the response is not adequate, surgery may be considered to alleviate the symptoms. Gastrostomy tube placement and/or addition of restriction, before reversal of the RYGB have been used as alternatives. Partial pancreatectomies are indicated only in exceptional cases.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Shantavasinkul PC, Torquati A, Corsino L. Post-gastric bypass hypoglycaemia: a review. Clin Endocrinol (Oxf). 2016;85:3–9.
Rariy CM, Rometo D, Korytkowski M. Post-gastric bypass hypoglycemia. Curr Diab Rep. 2016;16:19.
Marsk R, Jonas E, Rasmussen F, Naslund E. Nationwide cohort study of post-gastric bypass hypoglycaemia including 5,040 patients undergoing surgery for obesity in 1986–2006 in Sweden. Diabetologia. 2010;53:2307–11.
Kellogg TA, Bantle JP, Leslie DB, Redmond JB, Slusarek B, Swan T, et al. Postgastric bypass hyperinsulinemic hypoglycemia syndrome: characterization and response to a modified diet. Surg Obes Relat Dis. 2008;4:492–9.
Bueter M, Ashrafian H, le Roux CW. Mechanisms of weight loss after gastric by-pass and gastric banding. Obes Facts. 2009;2:325–31.
le Roux CW, Welbourn R, Werling M, et al. Gut hormones as mediators os appetite and weight loss after Roux-en-Y gastric by-pass. Ann Surg. 2007;246:780–5.
Schultes B, Ernst B, Wilms B, Thurnheer M, Hallschmid M. Hedonic hunger is increased in severely obese patients and is reduced after gastric by-pass surgery. Am J Clin Nutr. 2012;92:277–83.
Miras AD, le Roux CW. Bariatric surgery and taste: novel mechanisms of weight loss. Curr Opin Gastroenterol. 2010;26:140–5.
Tack J, Caenepeel P, De Wulf D, Bisschops R. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol. 2009;6:583–90.
Laurenius A, Werling M, le Roux CW, Fandriks L, Olbers T. More symptoms but similar blood glucose curve after oral carbohydrate provocation in patients with a history of hypoglycemia-like symptoms compared to asymptomatic patients after Roux-en-Y gastric by-pass. Surg Obes Relat Dis. 2014;10:1047–55.
Crapo PA, Scarlett JA, Kolterman OG, Sabders LR, Hofeldt FD, Olefsky JM. The effects of oral fructose, sucrose, and glucose in subjects with reactive hypoglycemia. Diabetes Care. 1982;5:512–7.
Zagury L, Moreira RO, Guedes EP, Coutinho WF, Appolinario JC. Insulinoma misdiagnosed as dumping syndrome after bariatric surgery. Obes Surg. 2004;14:120–3.
Harness JK, Geelhoed GW, Thompson NW, et al. Nesidioblastosis in adults. Arch Surg. 1981;116:575–80.
Service GJ, Thompson GB, Service JF, Andrews JC, Collazo-Clavell ML, Lloyd RV. Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric bypass surgery. N Engl J Med. 2005;353:249–54.
Z’graggen K, Guwweidhi A, Steffen R, et al. Severe recurrent hypoglycemia after gastric by-pass surgery. Obes Surg. 2008;18:981–8.
Holst JJ. Glucagonlike peptide 1: a newly discovered gastrointestinal hormone. Gastroenterology. 1994;107:1848–55.
Goldfine AB, Mun EC, Devine E, et al. Patients with neuroglycopenia after gastric by-pass surgery have exaggerated incretin and insulin secretory responses to a mixed meal. J Clin Endocrinol Metab. 2007;92:4678–85.
Rabiee A, Magruder JT, Salas-Carrillo R, et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric by-pass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction. J Surg Res. 2011;167:199–205.
Patti M, Goldfine AB. Hypoglycemia after gastric by-pass: the dark side of GLP-1. Gastroenterology. 2014;146:605–08. J Surg Res. 2011;167:199–205.
Meier JJ, Butler AE, Galasso R, Butler PC. Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased beta cell turnover. Diabetes Care. 2006;29:1554–9.
Butler PC, Meier JJ, Butler AE, Bhusshan A. The replication of beta cells in normal physiology, in disease and for therapy. Nat Clin Pract Endocrinol Metab. 2007;3:758–68.
Kamvissi V, Salerno A, Bornstein SR, Mingrone G, Rubino F. Incretins or -incretins? A new model for the ëntero-pancreatic axis. Horm Metab Res. 2015;47:84–7.
Tack J, Arts J, Caenepeel P, De Wulf D, Bisschops R. Pathophysiology, diagnosis and management of postoperative dumping syndrome. Nat Rev Gastroenterol Hepatol. 2009;6:583–56.
Cryer PE, Axelrod L, Grossman AB, et al. Evaluation and management of adult hypoglycemic disorders: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94:709–28.
Vezzosi D, Bennet A, Fauvel J, Caron P. Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycemia related to endogenous hyperinsulinism. Eur J Endocrinol. 2007;157:75–83.
Malik S, Mitchell JE, Steffen K, Engel S, Wiisanen R, Garcia L, et al. Recognition and management of hyperinsulinemic hypoglycemia after bariatric surgery. Obes Res Clin Pract. 2016;10:1–14.
Service FJ, Natt N, Thompson GB, et al. Noninsulinoma pancreatogenous hypoglycemia in adults independent of mutations in Kir6.2 and SURI genes. J Clin Endocrinol Metab. 1999;84:1582–9.
Bantle JP, Ilkramuddin S, Kellogg TA, Buchwald H. Hyperinsulinemic hypoglycemia developing later after gastric by-pass. Obes Surg. 2007;17:592–4.
Botros N, Rijnaarts I, Brandts H, Bleumink G, Janssen I, de Boer H. Effect of carbohydrate restriction in patients with hyperinsulinemic hypoglycemia after Roux-en Y gastric by-pass. Obes Surg. 2014;10:36–43.
Ritz P, Vaurs C, Bertrand M, Andruze Y, Guillaume E, Hanaire H. Usefulness of acarbose and dietery modifications to limit glycemic variability following Roux-en-Y gastric by-pass as assessed by continuous glucose monitoring. Diabetes Technol Ther. 2012;14:736–40.
Frankhouser SY, Ahmad AN, Peilli GA, Quintana BJ, Vengrove MA. Post-gastric-bypass hypoglycemia successfully treated with alpha-glucosidase inhibitor therapy. Endocr Pract. 2013;19:511–4.
Guseva N, Phillips D, Mordes JP. Successful treatment of persistent hyperinsulinemic hypoglycemia with nifedipine in an adult patient. Endocr Pract. 2010;16:107–11.
Spanakis E, Gragnoli C. Successful medical management of status post-Roux-en-Y-gastric by-pass hyperinsulinemic hypoglycemia. Obes Surg. 2009;19:1333–4.
Salehi M, Progeon RL, D’Alessio DA. Gastric by-pass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans. Diabetes. 2011;60:2308–14.
Salehi M, Gastaldelli A, D’Alessio DA. Altered islet function and insulin clearance cause hyperinsulinemia in gastric by-pass patients with symptoms of postprandial hypoglycemia. J Clin Endocrinol Metab. 2014;99:2008–17.
Salehi M, Gastaldelli A, D’Alessio DA. Blockade of glucagon-like peptide1 receptor corrects postprandial hypoglycemia after gastric by-pass. Gastroenterology. 2014;146:669–80.e2.
Didden P, Penning C, Masclee AA. Octreotide therapy in dumping syndrome: analysis of long term results. Aliment Pharmacol Ther. 2006;24:1367–75.
Cui Y, Elahi D, Anderson DK. Advances in the etiology and management of hyperinsulinemic hypoglycemia after Roux-en-Y gastric by-pass. J Gastrointest Surg. 2011;15:1879–88.
Campos GM, Ziemelis M, Paparodis R, Ahmed M, Davis DB. Laparoscopic reversal of Roux-en-Y gastric by-pass: technique and utility for treatment of endocrine complications. Surg Obes Relat Dis. 2014;10:36–43.
Vilallonga R, van de Vrande S, Himpens J. Laparoscopic reversal of Roux-en-Y gastric by-pass into normal anatomy with or without sleeve gastrectomy. Surg Endosc. 2013;27:4640–8.
de Heide LJ, Glaudemans AW, Oomen PH, Apers JA, Totté ER, van Beek AP. Functional imaging in hyperinsulinemic hypoglycemia after gastric bypass surgery for morbid obesity. J Clin Endroninol Metab. 2012;97:E963–7.
Z’graggen K, Guweidhi A, Steffen R, et al. Severe recurrent hypoglycemia after gastric by-pass surgery. Obes Surg. 2008;18:981–8.
Mala T. Postprandialhyperinsulinemic hypoglycemia after gastric by-pass surgical treatment. Surg Obes Relat Dis. 2014;10:1220–5.
Clancy TE, Moore FD Jr, Zimer MJ. Post-gastric by-pass hyperinsulinism with nesidioblastosis: subtotal or total pancreatectomy may be needed to prevent recurrent hypoglicemia. J Gastrointest Surg. 2006;10:1116–9.
Dapri G, Cadiere GB, Himpens J. Laparoscopic reconversion of Roux-en-Y gastric by-pass to original anatomy: technique and preliminary outcomes. Obes Surg. 2011;21:1289–95.
Lee CJ, Brown T, Magnuson TH, Egan JM, Carlson O, Elahi D. Hormonal response to a mixed-meal challenge after reversal of gastric by-pass for hypoglycemia. J Clin Endocrinol Metab. 2013;98:E1208–12.
Patti ME, McMahon G, Mun EC, et al. Severe hypoglycemia post-gastric by-pass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia. 2005;48:2236–40.
Ceppa EP, Ceppa DP, Omotosho PA, Dickerson JA 2nd, Park CW. Algorithm to diagnose etiology of hypoglycaemia after Roux-en-Y gastric by-pass for morbid obesity: case series and review of the literature. Surg Obes Relat Dis. 2012;8:641–7.
Qintar M, Sibai F, Taha M. Hypoglycemia due to an adult-onset nesidioblastosis, a diagnostic and management dilemma. Avicenna J Med. 2012;2:45–7.
Rabiee A, Magruder JT, Salas-Carrillo R, et al. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of the gut hormonal and pancreatic endocrine function. J Surg Res. 2011;167:199–205.
Alvarez GC, Faria EN, Beck M, Girardon DT, Machado AC. Laparoscopic spleen-reserving distal pancreatectomy as treatment for nesidioblastosis after gastric by-pass surgery. Obes Surg. 2007;17:550–2.
Barbour JR, Thomas BN, Morgan KA, Byrne TK, Adams DB. The practice of pancreatic resection after Roux-en-Y gastric by-pass. Am Surg. 2008;74:729–34.
Mathavan VK, Arregui M, Davis C, Singh K, Patel A, Meacham J. Management of postgastric by-pass noninsulinoma pancreatogenous hypoglycemia. Surg Endosc. 2010;24:2547–55.
Rumilla KM, Erickson LA, Service FJ, et al. Hyperinsulinemic hypoglycemia with nesidioblastosis: histological features and growth factor expression. Mod Pathol. 2009;22:239–45.
Ritz P, Hanaire H. Post-bypass hypoglycemia: a review of current findings. Diabetes Metab. 2011;37:274–81.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Switzerland AG
About this chapter
Cite this chapter
da Costa Alvarez, G. (2020). Hypoglycemia After Gastric Bypass. In: Ettinger, J., et al. Gastric Bypass. Springer, Cham. https://doi.org/10.1007/978-3-030-28803-7_35
Download citation
DOI: https://doi.org/10.1007/978-3-030-28803-7_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-28802-0
Online ISBN: 978-3-030-28803-7
eBook Packages: MedicineMedicine (R0)